Molecular Biomedicine（国际刊号）杂志
- 知网目次
- 主管单位：
- 主办单位：
四川省国际医学交流促进会、Springer Nature
- 国际刊号：
2662-8651
- 国内刊号：
- 创刊时间：
- 期刊类别：
- 出版社：
- 主编：
- 发行周期：
年刊
- 审稿周期：
个月
- 被引次数：
- 邮发代号：
- 全年定价：
- 他引率：
- 邮编：
- 影响因子:0
- 期刊分类:
- 发文量:
- h指数:
- 立即指数:
- 引用半衰期:
四川省国际医学交流促进会、Springer Nature
2662-8651
年刊
个月
--------https://www.editorialmanager.com/mbmc
《Molecular Biomedicine（国际刊号）》期刊已被查看： 次
杂志社官网：https://www.springer.com/journal/43556
投稿邮箱：molbiomed@med-cens.orgeditorial@molbiomed.org（官网邮箱）
主管单位：
主办单位：四川省国际医学交流促进会、Springer Nature
地址：
邮编：
邮发：
全年定价：；欢迎广大学者朋友联系Molecular Biomedicine（国际刊号）杂志社投稿订阅！
注意：本站并非《Molecular Biomedicine（国际刊号）》杂志社官网，不提供征稿投稿服务，仅整理介绍该杂志内容！投稿请直接咨询杂志社！
1、该刊只有国际刊号！
2、投稿方式：在线投稿。
3、官网网址：
https://www.springer.com/journal/43556
（微信公众号信息）
4、投稿系统：https://www.editorialmanager.com/mbmc
5、主办单位官网：https://www.scimea.cn/
（四川省国际医学交流促进会）
6、官网邮箱：molbiomed@med-cens.org（编辑部）
editorial@molbiomed.org（编辑部）
7、官方微信公众号：四川省国际医学交流促进会（scimea）
2022年3月18日星期五
Molecular Biomedicine简介
Molecular Biomedicine 是由全球领先出版商Springer Nature发行的同行评审在线OA期刊（https://www.springer.com/journal/43556），是中国科学院院士魏于全教授主编的又一高水平生物医学期刊。同时，魏院士还创办了Signal Transduction and Targeted Therapy（简称STTT ），2020年影响因子18.187，位于SCI期刊JCR分区Q1区，全球生物化学和分子生物类期刊排名第5、细胞生物学类期刊排名第11。相信Molecular Biomedicine 有院士领队，强大编委团队支持，定是潜力无限，未来可期。
Molecular Biomedicine主编由荷兰格罗宁根大学Arnold J.M. Driessen教授（荷兰皇家科学院院士）和四川大学华西医院生物治疗国家重点实验室魏于全教授（中国科学院院士）担任。编委团队由全球10多个国家的著名科学家构成，其中超过20%为国内外院士，80%以上为国外专家，包括董晨院士、高福院士、韩家淮院士、宋伟宏院士、丁楅森教授、邓宏魁教授等著名专家教授。自开放投稿以来，始终坚持高水平、国际化、严标准的办刊策略，所有刊载内容均经过严格的同行评审，专业高效的编辑团队管理，得到了国内外同行学者的广泛认可。
目前期刊已在线发表文章50余篇，通讯国际背景接近70%，其中包括鲁汶大学Anabelle Decottignies教授、耶鲁大学Darryl T. Martin、荷兰莱顿大学Pieter Velden教授、诺丁汉大学Srinivasan Madhusudan教授、哥伦比亚大学Akiva Mintz教授、宾夕法尼亚大学徐小威教授、北达科他大学吴敏教授、四川大学黄灿华教授、中南大学陶永光、南京大学何农跃教授等全球知名专家学者稿件。
Molecular Biomedicine（简称Mol Biomed ）是同行评审的在线发表开放获取 (OA) 期刊，及时出版基于分子角度的生物医学领域的基础研究与临床研究关注，重点关注人类疾病的发展机制、预防、诊断和治疗等方面的研究进展，感兴趣的主题包括表观遗传学、基因组学和蛋白质组学、基因编辑、RNA生物学、信号转导、结构生物学、疾病的早期诊断和生物标记、基因治疗、细胞治疗和免疫治疗、小分子靶向治疗、分子成像、医学人工智能、再生医学等。Molecular Biomedicine 发表论文类型包括综述（Review）、展望（Perspective）、研究论文（Research Article）、致编辑信函（Letter）、研究亮点（Research Highlight）等。Molecular Biomedicine 由衷地感谢期刊作者、审稿人和读者的巨大贡献, Molecular Biomedicine 将不断进步，发表更多高质量的论文，更好地服务于全球的读者和作者。
《Molecular Biomedicine》投稿指南
【官网信息】
Submission guidelines
Instructions for Authors
Article-Processing Charge
Molecular Biomedicine is an Open Access publication and an article-processing charge (APC) is levied on articles that are accepted for publication by the Editors.
The APC for this journal is covered by Sichuan International Medical Exchange & Promotion Association, in 2020-2022.
Article Types
Research
Articles describe original research, and should be 3000-6000 words (excluding the abstract, tables, figure legends and references) and contain no more than 8 display items (such as figures or tables).
Research papers should contain an unstructured abstract with up to 250 words. Additional display items will be published online as Supplemental Information.
Review
A review should be a comprehensive synthesis and/or analysis of specific topics. A short Introduction giving the rationale for the review should be followed by sections with appropriate subheadings, followed by a conclusions section at the end. The standard footer headings (Acknowledgements, Contributions, Competing Interests, and Funding) are required. All invited reviews will undergo peer review prior to acceptance.
Review papers should contain an unstructured abstract with up to 250 words, at least 3000 words in length. Review papers should contain around 4-8 figures and tables in total, around 100-500 references.
Letter
Letters provide rapid and concise report of a novel finding that is brief in nature but is of general interest to the field. There should be no more than 10 authors.
No abstract needed for Letter papers. It should include 1200 words max excluding references, figures and tables. A letter should contain, but no more than 1 display item and references are limited to 5.
Research Highlight
Research Highlights discuss the main advances made by the paper as well as putting the finds of the study into the proper context of the field.
A brief stand first of one or two sentences should serve as an abstract. A research highlight paper should include 1000 words max excluding references, figures and tables, and contain, but no more than 1 display item and references are limited to 5. A consensus should be a public statement on professional knowledge in the field of molecular biomedicine, and it is expected to be generally agreed upon as an evidence-based, state-of-the-art knowledge by a representative group of experts in that area.
Consensus
Consensus papers should contain an unstructured Abstract with up to 250 words. Four to Six Keywords representing the main content of the article. The Background section should a concise summary of a search of the existing literature and the issue under discussion. The standard footer headings (Acknowledgements, Contributions, Competing Interests, and Funding) are required.
Manuscript Submission
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Permissions
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Online Submission
Please follow the hyperlink “Submit manuscript” and upload all of your manuscript files following the instructions given on the screen.
Source Files
Please ensure you provide all relevant editable source files at every submission and revision. Failing to submit a complete set of editable source files will result in your article not being considered for review. For your manuscript text please always submit in common word processing formats such as .docx or LaTeX.
……
更多详情：
https://www.springer.com/journal/43556/submission-guidelines
Molecular Biomedicine（国际刊号）杂志被以下数据库收录：
杂志社官网：https://www.springer.com/journal/43556
投稿邮箱：molbiomed@med-cens.orgeditorial@molbiomed.org（官网邮箱）
Molecular Biomedicine（国际刊号）不是核心期刊,级别是：， 是：分类下的知网目次收录的期刊。
我们不是《Molecular Biomedicine（国际刊号）》杂志社。本站主要从事期刊信息展示与期刊推荐，不是任何杂志官网，直投稿件请联系杂志社。本站仅提供免费的学术指导、论文辅导、期刊投稿信息整理收集服务。
期刊发表的成功与否，主要取决于文章内容的质量。编辑老师会根据研究领域、创新性等多因素进行考量。优化投稿流程，避免频繁碰壁，缩短发表周期，节省您的宝贵时间，让您的学术成果快速发表
ChatGPt在科学论文写作中的潜在应用、实际效果以及面临的挑战与极限性。至于，Sci论文能用ChatGPt写吗？能用，但要注意ChatGPt写论文面临的挑战和
评职称用的正规课题材料申请流程就收到了相关主管部门下发的课题申报红头文件，然后开始执笔撰写申报材料，写好之后提交到单位科研科领导审核通过之后，单位就会帮你依托单位提交到相关部门去申报，申报公示立项，这是课题申报的流程。
